Global Recombinant DNA Technology Market Research Report 2024(Status and Outlook)

Global Recombinant DNA Technology Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Recombinant DNA Technology Market Size was estimated at USD 3291.61 million in 2023 and is projected to reach USD 5399.92 million by 2029, exhibiting a CAGR of 8.60% during the forecast period.

This report provides a deep insight into the global Recombinant DNA Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant DNA Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant DNA Technology market in any manner.

Global Recombinant DNA Technology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Monsanto Company

Roche

Biogen

Amgen

Novartis

Eli Lilly and Company

GenScript

Pfizer Inc.

Novo Nordisk

Sanofi

Merck KGaA

Profacgen

Biocon

GlaxoSmithKline

Cibus

Horizon Discovery Group

New England Biolabs

Market Segmentation (by Type)

Therapeutic Agent

Vaccine

Biotech Crops

Specialty Chemicals

Market Segmentation (by Application)

Biotechnology and Pharmaceutical Companies

Academic & Government Research Institutes

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Recombinant DNA Technology Market

Overview of the regional outlook of the Recombinant DNA Technology Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant DNA Technology Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Recombinant DNA Technology
1.2 Key Market Segments
1.2.1 Recombinant DNA Technology Segment by Type
1.2.2 Recombinant DNA Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Recombinant DNA Technology Market Overview
2.1 Global Market Overview
2.1.1 Global Recombinant DNA Technology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant DNA Technology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Recombinant DNA Technology Market Competitive Landscape
3.1 Global Recombinant DNA Technology Sales by Manufacturers (2019-2024)
3.2 Global Recombinant DNA Technology Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant DNA Technology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant DNA Technology Sales Sites, Area Served, Product Type
3.6 Recombinant DNA Technology Market Competitive Situation and Trends
3.6.1 Recombinant DNA Technology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant DNA Technology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Recombinant DNA Technology Industry Chain Analysis
4.1 Recombinant DNA Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Recombinant DNA Technology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Recombinant DNA Technology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant DNA Technology Sales Market Share by Type (2019-2024)
6.3 Global Recombinant DNA Technology Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant DNA Technology Price by Type (2019-2024)
7 Recombinant DNA Technology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant DNA Technology Market Sales by Application (2019-2024)
7.3 Global Recombinant DNA Technology Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant DNA Technology Sales Growth Rate by Application (2019-2024)
8 Recombinant DNA Technology Market Segmentation by Region
8.1 Global Recombinant DNA Technology Sales by Region
8.1.1 Global Recombinant DNA Technology Sales by Region
8.1.2 Global Recombinant DNA Technology Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant DNA Technology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant DNA Technology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant DNA Technology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant DNA Technology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant DNA Technology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Monsanto Company
9.1.1 Monsanto Company Recombinant DNA Technology Basic Information
9.1.2 Monsanto Company Recombinant DNA Technology Product Overview
9.1.3 Monsanto Company Recombinant DNA Technology Product Market Performance
9.1.4 Monsanto Company Business Overview
9.1.5 Monsanto Company Recombinant DNA Technology SWOT Analysis
9.1.6 Monsanto Company Recent Developments
9.2 Roche
9.2.1 Roche Recombinant DNA Technology Basic Information
9.2.2 Roche Recombinant DNA Technology Product Overview
9.2.3 Roche Recombinant DNA Technology Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Recombinant DNA Technology SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Biogen
9.3.1 Biogen Recombinant DNA Technology Basic Information
9.3.2 Biogen Recombinant DNA Technology Product Overview
9.3.3 Biogen Recombinant DNA Technology Product Market Performance
9.3.4 Biogen Recombinant DNA Technology SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Amgen
9.4.1 Amgen Recombinant DNA Technology Basic Information
9.4.2 Amgen Recombinant DNA Technology Product Overview
9.4.3 Amgen Recombinant DNA Technology Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Novartis
9.5.1 Novartis Recombinant DNA Technology Basic Information
9.5.2 Novartis Recombinant DNA Technology Product Overview
9.5.3 Novartis Recombinant DNA Technology Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Eli Lilly and Company
9.6.1 Eli Lilly and Company Recombinant DNA Technology Basic Information
9.6.2 Eli Lilly and Company Recombinant DNA Technology Product Overview
9.6.3 Eli Lilly and Company Recombinant DNA Technology Product Market Performance
9.6.4 Eli Lilly and Company Business Overview
9.6.5 Eli Lilly and Company Recent Developments
9.7 GenScript
9.7.1 GenScript Recombinant DNA Technology Basic Information
9.7.2 GenScript Recombinant DNA Technology Product Overview
9.7.3 GenScript Recombinant DNA Technology Product Market Performance
9.7.4 GenScript Business Overview
9.7.5 GenScript Recent Developments
9.8 Pfizer Inc.
9.8.1 Pfizer Inc. Recombinant DNA Technology Basic Information
9.8.2 Pfizer Inc. Recombinant DNA Technology Product Overview
9.8.3 Pfizer Inc. Recombinant DNA Technology Product Market Performance
9.8.4 Pfizer Inc. Business Overview
9.8.5 Pfizer Inc. Recent Developments
9.9 Novo Nordisk
9.9.1 Novo Nordisk Recombinant DNA Technology Basic Information
9.9.2 Novo Nordisk Recombinant DNA Technology Product Overview
9.9.3 Novo Nordisk Recombinant DNA Technology Product Market Performance
9.9.4 Novo Nordisk Business Overview
9.9.5 Novo Nordisk Recent Developments
9.10 Sanofi
9.10.1 Sanofi Recombinant DNA Technology Basic Information
9.10.2 Sanofi Recombinant DNA Technology Product Overview
9.10.3 Sanofi Recombinant DNA Technology Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Merck KGaA
9.11.1 Merck KGaA Recombinant DNA Technology Basic Information
9.11.2 Merck KGaA Recombinant DNA Technology Product Overview
9.11.3 Merck KGaA Recombinant DNA Technology Product Market Performance
9.11.4 Merck KGaA Business Overview
9.11.5 Merck KGaA Recent Developments
9.12 Profacgen
9.12.1 Profacgen Recombinant DNA Technology Basic Information
9.12.2 Profacgen Recombinant DNA Technology Product Overview
9.12.3 Profacgen Recombinant DNA Technology Product Market Performance
9.12.4 Profacgen Business Overview
9.12.5 Profacgen Recent Developments
9.13 Biocon
9.13.1 Biocon Recombinant DNA Technology Basic Information
9.13.2 Biocon Recombinant DNA Technology Product Overview
9.13.3 Biocon Recombinant DNA Technology Product Market Performance
9.13.4 Biocon Business Overview
9.13.5 Biocon Recent Developments
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Recombinant DNA Technology Basic Information
9.14.2 GlaxoSmithKline Recombinant DNA Technology Product Overview
9.14.3 GlaxoSmithKline Recombinant DNA Technology Product Market Performance
9.14.4 GlaxoSmithKline Business Overview
9.14.5 GlaxoSmithKline Recent Developments
9.15 Cibus
9.15.1 Cibus Recombinant DNA Technology Basic Information
9.15.2 Cibus Recombinant DNA Technology Product Overview
9.15.3 Cibus Recombinant DNA Technology Product Market Performance
9.15.4 Cibus Business Overview
9.15.5 Cibus Recent Developments
9.16 Horizon Discovery Group
9.16.1 Horizon Discovery Group Recombinant DNA Technology Basic Information
9.16.2 Horizon Discovery Group Recombinant DNA Technology Product Overview
9.16.3 Horizon Discovery Group Recombinant DNA Technology Product Market Performance
9.16.4 Horizon Discovery Group Business Overview
9.16.5 Horizon Discovery Group Recent Developments
9.17 New England Biolabs
9.17.1 New England Biolabs Recombinant DNA Technology Basic Information
9.17.2 New England Biolabs Recombinant DNA Technology Product Overview
9.17.3 New England Biolabs Recombinant DNA Technology Product Market Performance
9.17.4 New England Biolabs Business Overview
9.17.5 New England Biolabs Recent Developments
10 Recombinant DNA Technology Market Forecast by Region
10.1 Global Recombinant DNA Technology Market Size Forecast
10.2 Global Recombinant DNA Technology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant DNA Technology Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant DNA Technology Market Size Forecast by Region
10.2.4 South America Recombinant DNA Technology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant DNA Technology by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Recombinant DNA Technology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant DNA Technology by Type (2025-2030)
11.1.2 Global Recombinant DNA Technology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant DNA Technology by Type (2025-2030)
11.2 Global Recombinant DNA Technology Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant DNA Technology Sales (K Units) Forecast by Application
11.2.2 Global Recombinant DNA Technology Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings